---
schema_version: "secwatch.filing_event.v1"
accession: "0001736730-26-000004"
form_type: "8-K"
ticker: "CAMP"
cik: "0001736730"
company_name: "Camp4 Therapeutics Corp"
filed_at: "2026-01-09T23:59:59+00:00"
generated_at: "2026-05-16T11:04:40.690588+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# CAMP4 Therapeutics updates corporate presentation; no specific material changes disclosed

## Summary
- Company furnished an updated corporate presentation as Exhibit 99.1.
- Presentation is available on the Investors section of the company's website.
- No financial results, pipeline milestones, or guidance changes announced in the filing.
- The 8-K is a routine Regulation FD disclosure with no new material information.

## SEC filing metadata
- accession: 0001736730-26-000004
- form_type: 8-K
- ticker: CAMP
- cik: 0001736730
- company_name: Camp4 Therapeutics Corp
- filed_at: 2026-01-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1736730/000173673026000004/0001736730-26-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1736730/000173673026000004/camp-20260109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001736730-26-000004
- JSON: https://secwatch.observer/filing/0001736730-26-000004.json
- Plain text: https://secwatch.observer/filing/0001736730-26-000004.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.